A New Shingles Vaccine on the Horizon?

Released: 9/19/2017


Want to know the latest about protection against the painful shingles rash before sportscaster Terry Bradshaw (lately a pharmaceutical TV ad pitchman) knocks on your door? And wait a minute, wasn’t there already a shingles vaccine?


A vaccine called Zostavax is already in use to protect against shingles, and the CDC advises it for adults age 60 and older. But its effectiveness has been found to be limited. The New England Journal of Medicine is reporting on new research into an experimental vaccine that protected about 90 percent of adults age 70 and up. In addition, it had a four-year duration of effectiveness.


Anyone who has recovered from chickenpox may develop shingles, and almost one in every three Americans develop it in their lifetimes.


Overall, the best way to manage shingles is through prevention. Studies show that nearly all Americans age 40 and up have had chickenpox, even if they don't remember it.


For more details about the clinical trial of a new shingles vaccine, check out the UPI/HealthDay story here.